In addition, a study by Bussian and colleagues indicated that elimination of p16Ink4a-positive astrocytes and microglia in the MAPTP301SPS19 mouse model of tau-associated cognitive impairment prevents hyperphosphorylation of soluble and insoluble tau forms, gliosis and also cognitive decline [62]. This evidence concerns the gene MAPT and Cognitive impairment.